2028年までの欧州ヒト肝臓モデル市場予測 - 新型コロナウイルス感染症の影響と地域分析(肝臓オルガノイド、肝臓オンチップ、2Dモデル、3Dバイオプリンティングなど)、用途(創薬、教育など)ごと、およびエンドユーザー (製薬企業およびバイオテクノロジー企業、研究機関、その他)

TIPRE00026112 | Pages: 119 | Biotechnology | Nov 2021 | Type: Regional | Status: Published
ヨーロッパのヒト肝臓モデル市場は、2021年の84,347.25千米ドルから2028年までに1,87244.81千米ドルに成長すると予想されています。 2021 年から 2028 年にかけて 12.1% の CAGR で成長すると推定されています。\\n\\n英国、ドイツ、フランス、イタリア、スペインはヨーロッパの主要経済国です。動物実験モデルの代替開発への注目が高まることで、市場の成長が急拡大すると予想されます。医療業界の研究開発の高まりに伴い、研究に使用される動物の数も増加しています。これらの動物は前臨床試験に大量に必要となります。科学実験中の動物の痛み、苦痛、死は長い間議論のテーマとなってきました。いくつかの事例では、特に薬物毒性研究において、動物モデルが薬物に対する身体の反応を常に予測できるわけではないことが示されています。これは、人間の薬物と毒素の代謝が動物とは大きく異なり、実験で薬物代謝を研究することがほぼ不可能であるためです。実験用齧歯動物種などのモデル. 代替研究の分野は過去 30 年間で加速している. さらに、近年、この地域の研究活動における動物の使用を制限するいくつかの規制が導入されている. in vitro 試験などの方法、細胞培養、コンピューターシミュレーション、および新しいイメージング/分析技術が、動物の過度の使用を避けるための薬物および化学試験の代替手段として提案されています。統合するには、バイオインフォマティクスツール、インビトロ細胞培養、酵素スクリーニング、およびモデル生物が必要です。最新の分析技術、データ収集、統計手法を使用して代替プロトコルの結果を分析すると、信頼性の高い結果が得られます。さらに、これらの方法は時間もコスト効率も低く、必要な労働力も限られています。オルガノイドを作製するための三次元(3D)細胞培養の出現により、安全で効果的な薬物試験を提供し、動物実験の必要性を最小限に抑えるために、より関連性の高いヒトオルガノイドモデルが研究されています。できるだけ人体に近い環境を提供できる代替試験モデルを開発する必要がある。さまざまな研究機関が、医薬品開発や生物医学研究のための代替方法の開発に取り組んでいます。肝臓モデルは動物モデルの代替として機能するため、研究における動物の使用を減らすことに現在焦点が当てられており、ヨーロッパのヒト肝臓モデル市場の成長を支援すると予想されます。 \\n新型コロナウイルス感染症の場合、ヨーロッパ、特にフランスとロシアが大きな影響を受けています。現在の新型コロナウイルス感染症(COVID-19)の発生は、EUが資金提供した研究に不意を突かれたわけではない。欧州委員会の MSCA は、新型コロナウイルス感染症 COVID-19 やその他の感染症によってもたらされる課題の解決策を見つけるために優れた研究者を支援しています。また、新型コロナウイルス感染症関連の臨床試験の開始を促進するため、当局は承認申請の初期評価の迅速な承認手続きを許可した。しかし、新型コロナウイルス感染症の再拡大の波は、臨床試験施設の閉鎖により市場にさまざまな影響を及ぼしています。 Phesi氏の2020年9月の分析によると、世界の臨床試験施設の停止件数は6月にピークに達し、最初は減少したが再び増加し、第2相試験と第3相試験に重大な影響を与えた。あらゆる分野で世界経済の不確実性が高まっており、2021 年は世界中のほとんどの臨床開発組織にとって困難な年となることが予想されます。臨床研究は新しい治療法を開発し、病気についての理解を深めるために不可欠ですが、新型コロナウイルス感染症は多くの課題をもたらしています。この地域の政府は、新型コロナウイルス以外の治験を安全かつ持続的に再開することを計画しています。 2020年9月の時点で、NIHR臨床研究ネットワークのデータによると、新型コロナウイルス以外の研究が再開されており、研究の45%が募集中であることが示されている。さらに、オルガノイドは、EuroStemCell パートナーシップに基づいて研究者によって使用されています。たとえば、オーストリア科学アカデミーIMBA分子生物工学研究所の研究者を含む国際的な科学者グループは、オルガノイドにおけるSARS-CoV-2感染を遅らせ、すでに臨床試験中の薬剤の潜在的な阻止効果を実証した。研究者たちは、新型コロナウイルス感染症の発生を管理するためにさまざまな研究を行っています。したがって、研究活動の増加は、市場にとって重要な機会につながります。\\n\\n新しい機能とテクノロジーを使用して、ベンダーは新しい顧客を引き付け、新興市場での拠点を拡大できます。この要因は、ヨーロッパのヒト肝臓モデル市場を牽引する可能性があります。ヨーロッパのヒト肝臓モデル市場は、予測期間中に良好なCAGRで成長すると予想されます。 \\n\\nヨーロッパのヒト肝臓モデル市場の収益と 2028 年までの予測 (千米ドル) \\n\\nヨーロッパのヒト肝臓モデル市場のセグメンテーション \\nタイプ別のヨーロッパのヒト肝臓モデル市場\\n- 肝臓オルガノイド\\n- 肝臓オンチップ\\n- 2D モデル\\n- 3D バイオプリンティング\\n- その他\\n用途別欧州ヒト肝臓モデル市場\\n- 創薬\\n- 教育\\n- その他\\nエンドユーザー別欧州ヒト肝臓モデル市場\\n- 製薬およびバイオテクノロジー企業\\n- 研究機関 \\n- その他 \\nヨーロッパヒト肝臓モデル市場、国別\\n- ドイツ\\n- フランス\\n- 英国\\n- イタリア \\n- スペイン\\n- ヨーロッパのその他の地域\\nヨーロッパヒト肝臓モデル市場 - 言及されている企業 \\n- BioIVT\\n- CELLINK\\n- CN Bio Innovations\\n- Cyprio\\n- Emulate, Inc.\\n- InSphero\\n- Kerafast\\n- Kirkstall\\n- MIMETAS BV\\n- THERMOフィッシャー サイエンティフィック社\\n\\n
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Human Liver Models Market By Type
1.3.2 Europe Human Liver Models Market By Application
1.3.3 Europe Human Liver Models Market By End User
1.3.4 Europe Human Liver Models Market By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Human Liver Models Market Market Landscape
4.1 Overview
4.2 Europe PEST Analysis
4.3 Experts Opinion
5. Europe Human Liver Models Market Key Market Dynamics
5.1 Market Drivers
5.1.1 Surging Prevalence of Liver Diseases
5.1.2 Escalating Focus on Developing Alternatives for Animal Testing Models
5.2 Market Restraints
5.2.1 Overpriced Liver Models
5.3 Market Opportunities
5.3.1 Growing focus on Drug Discovery Activities
5.4 Future Trends
5.4.1 Increasing Technological Advancements in Organ Printing
5.1 Impact analysis
6. Human Liver Models Market Europe Analysis
6.1 Europe Human Liver Models Market Revenue Forecast and Analysis
7. Europe Human Liver Models Market Analysis By Type
7.1 Overview
7.2 Europe Human Liver Models Market Revenue Share, by Type (2021 and 2028)
7.3 Liver Organoids
7.3.1 Overview
7.3.2 Liver Organoids: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
7.4 Liver-on-a-chip
7.4.1 Overview
7.4.2 Liver-on-a-chip: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
7.5 2D Models
7.5.1 Overview
7.5.2 2D Models: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
7.6 3D Bioprinting
7.6.1 Overview
7.6.2 3D Bioprinting: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
7.7 Others
7.7.1 Overview
7.7.2 Others: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
8. Europe Human Liver Models Market Analysis By Application
8.1 Overview
8.2 Europe Human Liver Models Market Share, by Application, 2021 and 2028, (%)
8.3 Educational
8.3.1 Overview
8.3.2 Educational: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
8.4 Drug Discovery
8.4.1 Overview
8.4.2 Drug Discovery: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
8.5 Other
8.5.1 Overview
8.5.2 Other: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
9. Europe Human Liver Models Market Analysis By End User
9.1 Overview
9.2 Europe Human Liver Models Market Share, by End User, 2021 and 2028, (%)
9.3 Research Institutes
9.3.1 Overview
9.3.2 Research Institutes: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
9.4 Pharmaceutical and Biotechnology Companies
9.4.1 Overview
9.4.2 Pharmaceutical and Biotechnology Companies: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
9.5 Others
9.5.1 Overview
9.5.2 Others: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
10. Europe Human Liver Models Market Country Analysis
10.1 Europe: Human Liver Models Market
10.1.1 Overview
10.1.2 Europe: Human Liver Models Market, by Country, 2021 & 2028 (%)
10.1.2.1 Germany: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.1.1 Germany: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.1.2 Germany: Human Liver Models Market, by Type Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.1.3 Germany: Human Liver Models Market, by Application Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.1.4 Germany: Human Liver Models Market, by End User Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.2 France: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.2.1 France: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.2.2 France: Human Liver Models Market, by Type Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.2.3 France: Human Liver Models Market, by Application Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.2.4 France: Human Liver Models Market, by End User Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.3 UK: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.3.1 UK: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.3.2 UK: Human Liver Models Market, by Type Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.3.3 UK: Human Liver Models Market, by Application Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.3.4 UK: Human Liver Models Market, by End User Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.4 Spain: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.4.1 Spain: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.4.2 Spain: Human Liver Models Market, by Type Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.4.3 Spain: Human Liver Models Market, by Application Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.4.4 Spain: Human Liver Models Market, by End User Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.5 Italy: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.5.1 Italy: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.5.2 Italy: Human Liver Models Market, by Type Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.5.3 Italy: Human Liver Models Market, by Application Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.5.4 Italy: Human Liver Models Market, by End User Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.6 Rest of Europe: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.6.1 Rest of Europe: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.6.2 Rest of Europe: Human Liver Models Market, by Type Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.6.3 Rest of Europe: Human Liver Models Market, by Application Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.6.4 Rest of Europe: Human Liver Models Market, by End User Revenue and Forecast to 2028 (US$ Thousand)
11. Impact Of COVID-19 Pandemic on Europe Human Liver Models Market
11.1 Europe: Impact Assessment Of COVID-19 Pandemic
12. Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. Company Profiles
13.1 THERMO FISHER SCIENTIFIC INC.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Emulate, Inc.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 CN Bio Innovations
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 MIMETAS BV
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 InSphero
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 BioIVT
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 CELLINK
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Kerafast
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Cyprio
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Kirkstall
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms


LIST OF TABLES
Table 1. Europe Human Liver Models Market, Revenue and Forecast, 20192028 (US$ Thousand)
Table 2. Germany: Human Liver Models Market, by Type Revenue and Forecast to 2028 (US$ Thousand)
Table 3. Germany: Human Liver Models Market, by Application Revenue and Forecast to 2028 (US$ Thousand)
Table 4. Germany: Human Liver Models Market, by End User Revenue and Forecast to 2028 (US$ Thousand)
Table 5. France: Human Liver Models Market, by Type Revenue and Forecast to 2028 (US$ Thousand)
Table 6. France: Human Liver Models Market, by Application Revenue and Forecast to 2028 (US$ Thousand)
Table 7. France: Human Liver Models Market, by End User Revenue and Forecast to 2028 (US$ Thousand)
Table 8. UK: Human Liver Models Market, by Type Revenue and Forecast to 2028 (US$ Thousand)
Table 9. UK: Human Liver Models Market, by Application Revenue and Forecast to 2028 (US$ Thousand)
Table 10. UK: Human Liver Models Market, by End User Revenue and Forecast to 2028 (US$ Thousand)
Table 11. Spain: Human Liver Models Market, by Type Revenue and Forecast to 2028 (US$ Thousand)
Table 12. Spain: Human Liver Models Market, by Application Revenue and Forecast to 2028 (US$ Thousand)
Table 13. Spain: Human Liver Models Market, by End User Revenue and Forecast to 2028 (US$ Thousand)
Table 14. Italy: Human Liver Models Market, by Type Revenue and Forecast to 2028 (US$ Thousand)
Table 15. Italy: Human Liver Models Market, by Application Revenue and Forecast to 2028 (US$ Thousand)
Table 16. Italy: Human Liver Models Market, by End User Revenue and Forecast to 2028 (US$ Thousand)
Table 17. Rest of Europe: Human Liver Models Market, by Type Revenue and Forecast to 2028 (US$ Thousand)
Table 18. Rest of Europe: Human Liver Models Market, by Application Revenue and Forecast to 2028 (US$ Thousand)
Table 19. Rest of Europe: Human Liver Models Market, by End User Revenue and Forecast to 2028 (US$ Thousand)
Table 20. Organic Developments Done by Companies
Table 21. Inorganic Developments Done by Companies
Table 22. Glossary of Terms


LIST OF FIGURES
Figure 1. Europe Human Liver Models Market Segmentation
Figure 2. Europe Human Liver Models Market Segmentation, By Country
Figure 3. Europe Human Liver Models Market Overview
Figure 4. Liver Organoids Held the Largest Share in 2020
Figure 5. The UK to Show Significant Growth During Forecast Period
Figure 6. Europe and PEST Analysis
Figure 7. Europe Human Liver Models Market Impact Analysis of Drivers and Restraints
Figure 8. Europe Human Liver Models Market Revenue Forecast and Analysis
Figure 9. Europe Human Liver Models Market Revenue Share, by Type (2021 and 2028)
Figure 10. Europe Liver Organoids: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 11. Europe Liver-on-a-chip: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 12. Europe 2D Models: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 13. Europe 3D Bioprinting: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 14. Europe Others: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 15. Europe Human Liver Models Market Share, by Application, 2021 and 2028 (%)
Figure 16. Europe Educational: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 17. Europe Drug Discovery: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 18. Europe Other: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 19. Europe Human Liver Models Market Share, by End User, 2021 and 2028 (%)
Figure 20. Europe Research Institutes: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 21. Europe Pharmaceutical and Biotechnology Companies: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 22. Europe Others: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 23. Europe: Human Liver Models Market, by Key Country Revenue (2021) (USD Thousand)
Figure 24. Europe: Human Liver Models Market, by Country, 2021 & 2028 (%)
Figure 25. Germany: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
Figure 26. France: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
Figure 27. UK: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
Figure 28. Spain: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
Figure 29. Italy: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
Figure 30. Rest of Europe: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
Figure 31. Impact of COVID-19 Pandemic in European Country Markets

1. BioIVT
2. CELLINK
3. CN Bio Innovations
4. Cyprio
5. Emulate, Inc.
6. InSphero
7. Kerafast
8. Kirkstall
9. MIMETAS BV
10. THERMO FISHER SCIENTIFIC INC.

- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe human liver models market. - Highlights key business priorities in order to assist companies to realign their business strategies - The key findings and recommendations highlight crucial progressive industry trends in the Europe human liver models market, thereby allowing players across the value chain to develop effective long-term strategies - Develop/modify business expansion plans by using substantial growth offering developed and emerging markets - Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the human liver models market, as well as those hindering it - Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
$1800
Site License
$4000
$2400
Enterprise License
$5000
$3000